Navigation Links
Acumed Signs Agreement with Vivorte to Distribute its Orthobiologics Portfolio
Date:3/13/2020

Acumed LLC today announced that it has entered into an agreement with Vivorte Inc. to be the exclusive distributor of the Louisville-based company’s orthobiologics portfolio. Under the terms of the agreement, Acumed will employ its sales, marketing, and medical education expertise to distribute Vivorte’s calcium phosphate-based bone allograft (Trabexus) and calcium phosphate-based biocement (Fortera). Vivorte will continue to utilize its product development and manufacturing capabilities to support the distribution.

“As a leader in the orthopaedic sector, Acumed is committed to providing the most comprehensive clinical solutions to our surgeons and this partnership with Vivorte allows us to deliver a best-in-class portfolio of orthobiologic technologies,” said Jagi Gill, Vice President/General Manager of AcuVentures at Acumed. “The Trabexus and Fortera products provide our surgeons the distinguishing features of ease of use, strength, and remodeling that are requisite in premier bone allografts and bone void fillers.”

The Trabexus product line is a self-setting calcium phosphate matrix with engineered allograft bone particles for optimized compressive strength and resorptive characteristics. Fortera is an osteoconductive biocement that combines industry leading compressive strength with superior flow characteristics. In the US alone, the orthobiologics market is estimated to be in excess of $550 million, of which the synthetic allograft market occupies a significant and growing segment.

Mark Wagner, CEO of Vivorte, commented, “We have been pleased with the strong clinical support and adoption of our products in the market. Partnering with Acumed, we will reach more surgeons to the benefit of more patients, thereby extending the commercial footprint for our orthobiologic technologies. This works because the two companies share a common vision of delivering innovative solutions in a quality-first culture.”

About Acumed
Acumed is a global leader in developing innovative orthopaedic and medical solutions to improve patient care. Acumed has more than three decades of experience in the orthopaedic industry, with the mission of aiding the afflicted through the ingenuity of our minds, the labor of our hands, and the compassion of our hearts. Founded in 1988, Acumed is headquartered in Hillsboro, Oregon, with offices and a distribution network around the world. For more information, visit http://www.acumed.net.

Read the full story at https://www.prweb.com/releases/acumed_signs_agreement_with_vivorte_to_distribute_its_orthobiologics_portfolio/prweb16973753.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Encouraging signs for bee biodiversity
2. Light and nanoprobes detect early signs of infection
3. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
4. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
5. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
6. Switzerland signs the ELIXIR consortium agreement and contributes €35 million
7. Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis
8. A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
9. Quick test finds signs of diarrheal disease
10. Small non-coding RNAs could be warning signs of cancer
11. ARUP Labs signs agreement with UH Case Medical Center to distribute novel DEEPGEN HIV test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2020)... ... , ... Today CJ BIO announced the first in a series of Food ... phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a range ... 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT Annual ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered ... common and aggressive adult brain cancer—announced today the appointments of its first Senior ... with supporting the organization’s initiatives and overall vision. , "Senior Fellows are more ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... and Renovagen Ltd, a UK supplier and manufacturer of innovative portable renewable energy ... operations in the fight against the COVID-19 pandemic in Zambia. , One of ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... ... July 08, 2020 , ... Bode ... significant expansion of laboratory operations through its COVID-19 testing service, Bode-CARES . ... , Bode-CARES provides a turnkey solution that includes a comprehensive ...
(Date:7/10/2020)... LEXINGTON, Mass. (PRWEB) , ... July 09, 2020 ... ... novel approaches to cell therapy, today announced the hiring of Allen R. Nissenson, ... executive team and oversee the clinical development of Sentien’s lead product, SBI-101. ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , a leading ... despite many obstacles created as a result of COVID-19. As a provider at ... medical practices and medical manufacturers by expanding access to device offerings, technology services, ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a leading provider of sensor ... of all types to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ ... enabled business will provide a health performance index system that scores all aspects of ...
Breaking Biology Technology: